Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 19.38M
March 31, 2026 23.64M
December 31, 2025 28.41M
September 30, 2025 29.74M
June 30, 2025 22.45M
March 31, 2025 25.24M
December 31, 2024 12.49M
September 30, 2024 15.18M
June 30, 2024 15.23M
March 31, 2024 22.65M
December 31, 2023 12.89M
September 30, 2023 11.94M
June 30, 2023 16.75M
March 31, 2023 20.49M
Date Value
December 31, 2022 22.03M
September 30, 2022 27.45M
June 30, 2022 34.00M
March 31, 2022 41.08M
December 31, 2021 40.16M
September 30, 2021 24.12M
June 30, 2021 27.66M
March 31, 2021 34.92M
December 31, 2020 11.97M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 11.08M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc 493.23M
Cellectis SA 267.36M
Akari Therapeutics Plc 38.62M
DBV Technologies SA --
argenx SE --

Total Assets (Quarterly) Related Metrics